NeuroOne Medical (NMTC) Issues Letter to Shareholders

Go back to NeuroOne Medical (NMTC) Issues Letter to Shareholders

NeuroOne® Issues Letter to Shareholders

April 16, 2025 9:00 AM EDT

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs

EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has issued a letter to shareholders from CEO, Dave Rosa.

Dear Shareholders,

In recent months, NeuroOne has achieved several significant milestones, including the expansion of our commercial... More